Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Buy
1,273
+765
+151% +$82.3K ﹤0.01% 1220
2026
Q1
$52K Buy
508
+320
+170% +$32.6K ﹤0.01% 1695
2025
Q4
$18.9K Buy
188
+13
+7% +$1.28K ﹤0.01% 2144
2025
Q3
$15.1K Buy
175
+75
+75% +$5.93K ﹤0.01% 2236
2025
Q2
$7.63K Buy
100
+99
+9,900% +$7.24K ﹤0.01% 2443
2025
Q1
$71 Sell
1
-28
-97% -$2.19K ﹤0.01% 3278
2024
Q4
$2.27K Sell
29
-1
-3% -$93 ﹤0.01% 2836
2024
Q3
$3.07K Buy
+30
New +$2.49K ﹤0.01% 2710

Other funds holding NUVL

SignatureFD's NUVL Position: Q2 2026 in Review

SignatureFD increased its Nuvalent (NUVL) stake by 151% in Q2 2026, buying an estimated $82.3K and bringing the position to 1,273 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

SignatureFD first reported a position in NUVL in Q3 2024 and has held it in 8 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • SignatureFD held 1,273 shares of Nuvalent worth $157K as of Q2 2026.
  • SignatureFD bought 765 Nuvalent shares in Q2 2026, an estimated $82.3K.
  • Nuvalent made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1220 holding.
  • SignatureFD first reported a position in Nuvalent in Q3 2024 and has held it in 8 quarters since.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.